Delivery Order SPE2DB22D3004-SPE2DB24FQC04
Award Date 4/23/24
Potential Completion Date 4/24/24
Potential Value $12K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a major pharmaceutical distributor, a $6,403.66 firm fixed-price delivery order contract for TWINRIX VACCINE SYRINGEML. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that Amerisourcebergen holds with DLA Troop Support Medical to provide a comprehensive range of medical commodities, including pharmaceutical products, to support military treatment programs and facilities...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the TWINRIX VACCINE SYRINGE medication. The $13,660.52 contract has a performance period through March 8, 2024 and does not include any set-aside designation. Amerisourcebergen Drug Corp has received numerous similar pharmaceutical and medical supply contracts from DLA to support military treatment programs and...
- The Defense Logistics Agency (DLA) awarded a $1,008.53 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the TWINRIX VACCINE SYRINGE ML product. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceuticals and medical supplies to DLA Troop Support Medical facilities...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $2,348.52 to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of TWINRIX VACCINE SYRINGEML, and has a period of performance through June 10, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with DLA valued at up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $231,266.24 firm fixed price delivery order contract to provide TWINRIX VACCINE SYRINGEML. This order is part of an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract (SPE2DB20D2002|SPE2DB24FL31A) worth $1,779.70 to provide the TWINRIX VACCINE SYRINGEML product. The contract has an ultimate completion date of March 12, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the TWINRIX VACCINE SYRINGEML product. The contract, valued at $1,408.95, has an ultimate completion date of March 25, 2024. This delivery order is part of a larger, single-award indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued up to $999,999,999.00 through December 31, 2025, to...
- The Defense Logistics Agency (DLA) awarded a $139,253.64 firm-fixed-price delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TWINRIX vaccine syringes. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp for the supply of TWINRIX vaccine syringes. The contract, valued at $1,846.48, has a completion date of July 24, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a prime contractor and for-profit organization, to provide the TWINRIX VACCINE SYRINGE ML product. The $9,131.33 delivery order has a completion date of February 6, 2024. Amerisourcebergen Drug Corp is a subsidiary of Amerisourcebergen Corporation and serves as the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00...